Quality of Surgical Outcome Reporting in Randomised Clinical Trials of Multimodal Rectal Cancer Treatment: A Systematic Review

被引:0
作者
Janczak, Joanna [1 ]
Ukegjini, Kristjan [2 ]
Bischofberger, Stephan [2 ]
Turina, Matthias [3 ]
Mueller, Philip C. [4 ]
Steffen, Thomas [2 ]
Hewitt, Brock
机构
[1] Hosp Reg Furstenland Toggenburg, Clin Gen & Visceral Surg, CH-9500 Wil, Switzerland
[2] Hosp Canton St Gallen, Dept Surg, CH-9007 St Gallen, Switzerland
[3] Univ Hosp Zurich, Dept Surg & Transplantat, CH-8091 Zurich, Switzerland
[4] Clarunis Univ, Dept Surg, Ctr Gastrointestinal & Hepatopancreatobiliary Dis, CH-4002 Basel, Switzerland
关键词
rectal cancer; radiotherapy; chemotherapy; randomised controlled trials; surgical quality; TOTAL MESORECTAL EXCISION; PHASE-III TRIAL; MEDIAN FOLLOW-UP; NEOADJUVANT CHEMORADIOTHERAPY REGIMENS; POSTOPERATIVE ADJUVANT CHEMOTHERAPY; FLUOROURACIL-BASED CHEMOTHERAPY; PREOPERATIVE RADIATION-THERAPY; SHORT-COURSE RADIOTHERAPY; OPEN-LABEL; LOCAL RECURRENCE;
D O I
10.3390/cancers16010026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Reporting surgical outcome and complication data in RCTs on rectal cancer is important because it is the basis for judging whether the results of a study warrant a change in clinical practice. In this review, we systematically analysed the quality of reporting in RCTs and the completeness rate of reporting of surgical outcomes and complication data. We found that only 2% (N = 7) of the RCTs met all 14 reporting criteria, and nearly half (N = 168, 49%) completed the procedure-specific quality criteria noted in the article. The most underreported criteria included complication severity (15% of articles).Abstract Introduction: Randomised controlled trials (RCTs) continue to provide the best evidence for treatment options, but the quality of reporting in RCTs and the completeness rate of reporting of surgical outcomes and complication data vary widely. The aim of this study was to measure the quality of reporting of the surgical outcome and complication data in RCTs of rectal cancer treatment and whether this quality has changed over time. Methods: Eligible articles with the keywords ("rectal cancer" OR "rectal carcinoma") AND ("radiation" OR "radiotherapy") that were RCTs and published in the English, German, Polish, or Italian language were identified by reviewing all abstracts published from 1982 through 2022. Two authors independently screened and analysed all studies. The quality of the surgical outcome and complication data was assessed based on fourteen criteria, and the quality of RCTs was evaluated based on a modified Jadad scale. The primary outcome was the quality of reporting in RCTs and the completeness rate of reporting of surgical results and complication data. Results: A total of 340 articles reporting multimodal therapy outcomes for 143,576 rectal cancer patients were analysed. A total of 7 articles (2%) met all 14 reporting criteria, 13 met 13 criteria, 27 met from 11 to 12 criteria, 36 met from 9 to 10 criteria, 76 met from 7 to 8 criteria, and most articles met fewer than 7 criteria (mean 5.5 criteria). Commonly underreported criteria included complication severity (15% of articles), macroscopic integrity of mesorectal excision (17% of articles), length of stay (18% of articles), number of lymph nodes (21% of articles), distance between the tumour and circumferential resection margin (CRM) (26% of articles), surgical radicality according to the site of the primary tumour (R0 vs. R1 + R2) (29% of articles), and CRM status (38% of articles). Conclusion: Inconsistent surgical outcome and complication data reporting in multimodal rectal cancer treatment RCTs is standard. Standardised reporting of clinical and oncological outcomes should be established to facilitate comparing studies and results of related research topics.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Evolution of Surgical Treatment for Rectal Cancer: a Review
    Sanjeev Dayal
    Nick Battersby
    Tom Cecil
    Journal of Gastrointestinal Surgery, 2017, 21 : 1166 - 1173
  • [22] Reporting on invasive lobular breast cancer in clinical trials: a systematic review
    Van Baelen, Karen
    Van Cauwenberge, Josephine
    Maetens, Marion
    Beck, Gabriela
    Camden, Ann
    Chase, Megan-Claire
    Fraser, Valerie
    Freeney, Siobhan
    Hutcheson, Laurie
    Levine, Julia K.
    Lien, Tone
    Terveer, Rian
    Turner, Claire
    Senkus, Elzbieta
    Jankowitz, Rachel C.
    Vandecaveye, Vincent
    Floris, Giuseppe
    Neven, Patrick
    Wildiers, Hans
    Sawyer, Elinor
    Vincent-Salomon, Anne
    Derksen, Patrick W. B.
    Desmedt, Christine
    NPJ BREAST CANCER, 2024, 10 (01)
  • [23] Surgical quality assurance in rectal cancer treatment: the key to improved outcome
    Peeters, KCMJ
    van de Velde, CJH
    EJSO, 2005, 31 (06): : 630 - 635
  • [24] Neoadjuvant treatment for locally advanced rectal cancer: a systematic review
    Keisuke Uehara
    Masato Nagino
    Surgery Today, 2016, 46 : 161 - 168
  • [25] Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials
    Zikos, Efstathios
    Ghislain, Irina
    Coens, Corneel
    Ediebah, Divine E.
    Sloan, Elizabeth
    Quinten, Chantal
    Koller, Michael
    van Meerbeeck, Jan P.
    Flechtner, Hans-Henning
    Stupp, Roger
    Pallis, Athanasios
    Czimbalmos, Agnes
    Sprangers, Mirjam A. G.
    Bottomley, Andrew
    LANCET ONCOLOGY, 2014, 15 (02) : E78 - E89
  • [26] A Comprehensive Review of Randomized Clinical Trials Shaping the Landscape of Rectal Cancer Therapy
    Franke, Aaron J.
    Skelton, William Paul
    George, Thomas J.
    Iqbal, Atif
    CLINICAL COLORECTAL CANCER, 2021, 20 (01) : 1 - 19
  • [27] Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review
    Teo, Mark T. W.
    McParland, Lucy
    Appelt, Ane L.
    Sebag-Montefiore, David
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (01): : 146 - 158
  • [28] Can we increase the chance of sphincter saving surgery in rectal cancer with neoadjuvant treatments: Lessons from a systematic review of recent randomized trials
    Gerard, Jean-Pierre
    Rostom, Yousri
    Gal, Jocelyn
    Benchimol, Daniel
    Ortholan, Cecile
    Aschele, Carlo
    Levi, Jean-Michel Hannoun
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 81 (01) : 21 - 28
  • [29] Reporting of post-protocol therapies in metastatic breast cancer registration clinical trials: A systematic review
    Shachar, Shlomit Strulov
    Korzets, Yasmin
    Shepshelovich, Daniel
    Zlothover, Noa
    Amir, Eitan
    Tibau, Ariadna
    Goldvaser, Hadar
    CANCER TREATMENT REVIEWS, 2024, 122
  • [30] The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: A systematic review
    Dirven, Linda
    Taphoorn, Martin J. B.
    Reijneveld, Jaap C.
    Blazeby, Jane
    Jacobs, Marc
    Pusic, Andrea
    La Sala, Edoardo
    Stupp, Roger
    Fayers, Peter
    Efficace, Fabio
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (14) : 2432 - 2448